RXO RXO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 19.3%-1.5pp | 19.7%-2.0pp | 19.8%-3.8pp | 20.2%-3.9pp | 20.7%-3.4pp | |
| Operating margin | -1.3%+0.1pp | -1.4%-0.1pp | -1%-0.6pp | -1.3%-1.5pp | -1.5%-2.0pp | |
| Net margin | -1.8%+4.2pp | -1.7%+4.6pp | -1.3%+5.5pp | -5.5%-5.0pp | -6%-5.7pp | |
| Returns | ||||||
| Return on equity | -6.8%+21.4pp | -6.3%+19.9pp | -4.9%+18.6pp | -28.4%-24.8pp | -28.2%-26.3pp | |
| Return on invested capital | -3.4%+0.9pp | -3.5%-0.3pp | -2.7%-1.6pp | -4.3%-5.0pp | -4.3%-6.3pp | |
| Efficiency | ||||||
| Asset turnover | 1.7×-0.2× | 1.7×0.0× | 1.8×+0.4× | 2.2×+0.2× | 2×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.3×0.0× | 1.3×0.0× | 1.3×0.0× | 1.3×+0.2× | 1.3×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×-0.6× | 0.4×-0.6× | |
| Net debt / EBITDA | 21×-2.6× | 18.2×-2.8× | 11.2×-1.8× | 16.1×+7.6× | 23.7×+17.0× | |
| Per Share | ||||||
| Book value per share | $8.92-5.5% | $9.15-24.3% | $9.37-23.9% | $9.42+91.4% | $9.45+90.2% | |
| Valuation | ||||||
| Market capitalization | $2.4B-23.0% | $2.07B-45.9% | $2.52B-44.1% | $2.63B-37.6% | $3.12B-11.2% | |
| Price / sales | 0.4×-0.2× | 0.4×-0.5× | 0.4×-0.7× | 0.5×-0.6× | 0.6×-0.3× | |
| Price / book | 1.6×-0.4× | 1.3×-1.0× | 1.6×-1.1× | 1.7×-5.6× | 2×-4.1× | |
| EV / EBITDA | 93.8×-37.5× | 74.2×-70.4× | 53.2×-48.3× | 78.7×+11.7× | 131.2×+84.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are RXO's profit margins?
- RXO (RXO) runs a 19.3% gross margin and a -1.3% operating margin, with a -1.8% net margin.
- Where do RXO's ratios come from?
- Every ratio is computed from RXO's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
